Diffusion Pharmaceuticals Inc. Business Finance Contracts & Agreements
82 Contracts & Agreements
- Investment Agreements (3 contracts)
- Note Agreements (6)
- Purchase Agreements (8)
- Registration Rights Agreements (3)
- Security Agreements (2)
- Share Agreements (1)
- Stock Agreements (10)
- Subscription Agreements (4)
- Underwriting Agreements (4)
- Warrant Agreements (41)
- Securities Purchase Agreement, dated March 28, 2024, by and between CervoMed Inc. and each of the purchasers party thereto (Filed With SEC on March 28, 2024)
- Form of Series A Warrant (Filed With SEC on March 28, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on March 28, 2024)
- Amendment to Pre-Funded Warrant, dated as February 26, 2024, by and between CervoMed Inc. and The Joshua S. Boger 2021 Trust DTD 12/09/2021 (Filed With SEC on February 28, 2024)
- Subscription Agreement, dated July 10, 2023 (Filed With SEC on November 13, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on August 17, 2023)
- Form of AI EIPP Holdings LLC Warrant (Filed With SEC on August 17, 2023)
- Form of Warrant (Filed With SEC on August 17, 2023)
- Form of Subscription Agreement between Diffusion Pharmaceuticals Inc. and the investors named therein, dated March 18, 2022 (Filed With SEC on March 18, 2022)
- Form of Underwriter Warrant (Filed With SEC on February 18, 2021)
- Amended & Restated Underwriting Agreement, dated February 11, 2021, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 18, 2021)
- Form of Securities Purchase Agreement, dated May 18, 2020, by and among the Company and the purchasers party thereto (Filed With SEC on May 20, 2020)
- Form of Warrant (Filed With SEC on May 20, 2020)
- Warrant Exercise Agreement, dated May 6, 2020, by and between Diffusion Pharmaceuticals Inc. and the purchaser thereto (Filed With SEC on May 8, 2020)
- Form of Placement Agent Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)
- Form of New Warrant issued on May 8, 2020 (Filed With SEC on May 8, 2020)
- Form of Securities Purchase Agreement, dated December 11, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on December 13, 2019)
- Form of Placement Agent Warrant (Filed With SEC on December 13, 2019)
- Form of Warrant (Filed With SEC on December 13, 2019)
- Securities Purchase Agreement (Filed With SEC on November 13, 2019)
- Form of Wainwright Warrant (Filed With SEC on November 13, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 13, 2019)
- Form of Series II Warrant (Filed With SEC on November 13, 2019)
- Form of Series I Warrant (Filed With SEC on November 13, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on November 8, 2019)
- Form of Placement Agents Warrant (Filed With SEC on November 8, 2019)
- Form of Underwriters Warrant (Filed With SEC on November 8, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on November 8, 2019)
- Form of Common Warrant (Filed With SEC on November 8, 2019)
- Form of Underwriters Warrant (Filed With SEC on October 28, 2019)
- Form of Pre-Funded Warrant (Filed With SEC on October 28, 2019)
- Form of Common Warrant (Filed With SEC on October 28, 2019)
- Form of Underwriting Agreement, dated [_______], by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on October 28, 2019)
- Form of Securities Purchase Agreement, dated May 23, 2019, by and among the Company and the purchasers party thereto (Filed With SEC on May 28, 2019)
- Form of Placement Agent Warrant (Filed With SEC on May 28, 2019)
- Form of Warrant (Filed With SEC on May 28, 2019)
- Form of Diffusion Pharmaceuticals Inc. Stock Option Award Agreement (Filed With SEC on April 2, 2018)
- Form of Underwriters Warrant (Filed With SEC on January 22, 2018)
- Form of Warrant (Filed With SEC on January 19, 2018)
- Underwriting Agreement, dated January 18, 2018, by and between Diffusion Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 19, 2018)